Tech Launch Arizona’s second Student Innovation Challenge has selected five student teams for funding to prototype inventions for commercialization.
Read about our metrics, a record number of startups, how we're engaging students, our efforts to increase diversity and inclusion and more. Visit the TLA Annual Report online.
UArizona researchers have developed a method of using ketamine in the treatment of Parkinson’s disease. The discovery has been licensed to Pharmather Inc., for development and commercialization.
The University of Arizona has developed a new chemical process for radio-labeling PET contrast agents that has now been licensed to startup TheraCea Pharma.
Along with honoring the awardees, the online commemorative website profiles nine innovative university research teams and the inventions and startups they are working to bring to the world.
The high-efficiency photovoltaic system licensed by Gen3 captures more heat and energy than currently available solar panels.
The NAI has named four distinguished faculty members with the honor, highlighting their commitment to scientific discovery and improving the human condition.
Tech Launch Arizona funds UArizona student innovation to develop solutions for the marketplace.
The technology has been licensed to a global medical company and is used by half a million people worldwide, including the inventor himself.
With 19 new companies added to its roster last fiscal year, the university has now launched more than 100 startups since revamping its commercialization operation in late 2012.